Gene Expression Profile in Experimental Mesangial Proliferative Glomerulonephritis

  • Izumi Yasukatsu
    Department of Pharmacology, Osaka City University Graduate School of Medical Science
  • Izumiya Yasuhiro
    Department of Pharmacology, Osaka City University Graduate School of Medical Science
  • Shiota Masayuki
    Department of Pharmacology, Osaka City University Graduate School of Medical Science
  • Yukimura Tokihito
    Department of Pharmacology, Osaka City University Graduate School of Medical Science
  • Shiojima Satoshi
    Department of Genomic Drug Discovery Science, Kyoto University Graduate School of Pharmaceutical Sciences
  • Yamada Masateru
    Pharmaceutical Research Laboratories, Toray Industries, Inc.
  • Kadowaki Tadashi
    Department of Genomic Drug Discovery Science, Kyoto University Graduate School of Pharmaceutical Sciences
  • Katsuma Susumu
    Department of Genomic Drug Discovery Science, Kyoto University Graduate School of Pharmaceutical Sciences
  • Hirasawa Akira
    Department of Genomic Drug Discovery Science, Kyoto University Graduate School of Pharmaceutical Sciences
  • Tsujimoto Gozoh
    Department of Genomic Drug Discovery Science, Kyoto University Graduate School of Pharmaceutical Sciences
  • Iwao Hiroshi
    Department of Pharmacology, Osaka City University Graduate School of Medical Science

Search this article

Abstract

We analyzed gene expression in rat anti-Thy1 antibody-induced glomerulonephritis by using the cDNA microarray method. Ninety-seven genes that differed by more than 1.5-fold intensity in comparison with the controls were selected. Cluster analysis showed that the expression of genes associated with inflammation reached maximum levels at 24 h, while genes involved in the development of fibrosis increased at 7 days after injection. Microarray analysis of animal disease models may be a powerful approach for understanding the gene expression programs that underlie these disorders.<br>

Journal

Citations (2)*help

See more

References(14)*help

See more

Details 詳細情報について

Report a problem

Back to top